Veru (VERU) Competitors $0.71 0.00 (-0.34%) (As of 09:57 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends VERU vs. NUS, NATR, MED, EL, IPAR, PBH, HLF, USNA, GHRS, and ALMSShould you be buying Veru stock or one of its competitors? The main competitors of Veru include Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Estée Lauder Companies (EL), Inter Parfums (IPAR), Prestige Consumer Healthcare (PBH), Herbalife (HLF), USANA Health Sciences (USNA), GH Research (GHRS), and Alumis (ALMS). Veru vs. Nu Skin Enterprises Nature's Sunshine Products Medifast Estée Lauder Companies Inter Parfums Prestige Consumer Healthcare Herbalife USANA Health Sciences GH Research Alumis Veru (NASDAQ:VERU) and Nu Skin Enterprises (NYSE:NUS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, community ranking, earnings, profitability, institutional ownership, media sentiment, valuation and risk. Which has more volatility & risk, VERU or NUS? Veru has a beta of -0.5, suggesting that its share price is 150% less volatile than the S&P 500. Comparatively, Nu Skin Enterprises has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Does the media refer more to VERU or NUS? In the previous week, Veru had 1 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 4 mentions for Veru and 3 mentions for Nu Skin Enterprises. Nu Skin Enterprises' average media sentiment score of 1.22 beat Veru's score of 0.43 indicating that Nu Skin Enterprises is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veru 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Nu Skin Enterprises 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor VERU or NUS? Nu Skin Enterprises received 241 more outperform votes than Veru when rated by MarketBeat users. However, 69.67% of users gave Veru an outperform vote while only 64.00% of users gave Nu Skin Enterprises an outperform vote. CompanyUnderperformOutperformVeruOutperform Votes27169.67% Underperform Votes11830.33% Nu Skin EnterprisesOutperform Votes51264.00% Underperform Votes28836.00% Do analysts rate VERU or NUS? Veru presently has a consensus target price of $4.00, indicating a potential upside of 462.67%. Nu Skin Enterprises has a consensus target price of $8.88, indicating a potential upside of 20.42%. Given Veru's stronger consensus rating and higher possible upside, equities analysts clearly believe Veru is more favorable than Nu Skin Enterprises.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veru 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Nu Skin Enterprises 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has preferable earnings & valuation, VERU or NUS? Nu Skin Enterprises has higher revenue and earnings than Veru. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Veru, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeru$14.09M7.38-$93.15M-$0.48-1.48Nu Skin Enterprises$1.97B0.19$8.60M-$2.07-3.56 Is VERU or NUS more profitable? Nu Skin Enterprises has a net margin of -5.81% compared to Veru's net margin of -376.38%. Nu Skin Enterprises' return on equity of 5.47% beat Veru's return on equity.Company Net Margins Return on Equity Return on Assets Veru-376.38% -115.99% -66.94% Nu Skin Enterprises -5.81%5.47%2.46% Do institutionals and insiders hold more shares of VERU or NUS? 47.2% of Veru shares are held by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are held by institutional investors. 14.2% of Veru shares are held by company insiders. Comparatively, 1.7% of Nu Skin Enterprises shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryVeru and Nu Skin Enterprises tied by winning 9 of the 18 factors compared between the two stocks. Ad Porter & CompanyHow to piss off your liberal friends… and profit from itElon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now Get Veru News Delivered to You Automatically Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERU vs. The Competition Export to ExcelMetricVeruPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$104.06M$6.85B$5.15B$9.28BDividend YieldN/A3.06%4.81%4.06%P/E Ratio-1.4810.79135.4217.51Price / Sales7.38286.571,184.62142.21Price / CashN/A56.6540.4237.95Price / Book3.235.404.894.94Net Income-$93.15M$152.04M$118.71M$225.59M7 Day Performance-3.23%-4.19%15.74%-1.07%1 Month Performance20.45%2.70%15.70%7.23%1 Year Performance4.56%17.16%34.85%22.97% Veru Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VERUVeru2.1313 of 5 stars$0.71-0.3%$4.00+462.7%-6.1%$104.06M$14.09M-1.48189Earnings ReportNews CoverageGap DownNUSNu Skin Enterprises4.315 of 5 stars$7.34-2.0%$8.88+20.9%-62.2%$364.88M$1.78B-3.593,700Positive NewsNATRNature's Sunshine Products3.3694 of 5 stars$15.64+0.2%$19.00+21.5%-5.2%$288.97M$445.10M17.55814MEDMedifast1.3306 of 5 stars$18.08-5.6%$17.00-6.0%-72.8%$197.76M$674.48M29.03870ELEstée Lauder Companies4.9292 of 5 stars$79.41-0.8%$98.57+24.1%-45.6%$28.51B$15.61B142.9362,000Short Interest ↓Positive NewsIPARInter Parfums4.0972 of 5 stars$135.88-0.2%$159.75+17.6%-5.5%$4.35B$1.42B29.36530Analyst ForecastShort Interest ↑Positive NewsPBHPrestige Consumer Healthcare3.8834 of 5 stars$82.65+0.4%$85.25+3.1%+34.2%$4.08B$1.11B20.02540Positive NewsHLFHerbalife4.6849 of 5 stars$7.25-3.1%$9.90+36.6%-51.9%$730.74M$5.00B8.669,200USNAUSANA Health Sciences2.7941 of 5 stars$36.58-0.2%$35.00-4.3%-30.7%$697.22M$921.01M12.951,800GHRSGH Research1.9124 of 5 stars$8.20+5.9%$35.67+335.0%+51.3%$426.63MN/A-9.8010Positive NewsALMSAlumisN/A$8.63+2.9%$26.83+210.9%N/A$407.53MN/A0.00N/ANews CoveragePositive News Related Companies and Tools Related Companies NUS Alternatives NATR Alternatives MED Alternatives EL Alternatives IPAR Alternatives PBH Alternatives HLF Alternatives USNA Alternatives GHRS Alternatives ALMS Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VERU) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veru Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veru With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.